Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Two new history entries were added on 2026-04-09 and 2026-04-30 (versions 440 and 441) reflecting updates to the Study Status and Contacts/Locations sections, with a subsequent entry on 2026-05-01 referencing these changes. The 2026-03-04 entry was deleted.
    Difference
    0.1%
    Check dated 2026-05-03T19:47:44.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    This updates the displayed ClinicalTrials.gov interface/release version from v3.5.0 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:35:47.000Z thumbnail image
  4. Check
    55 days ago
    Change Detected
    Summary
    Addition of Revision: v3.5.0 and deletion of Revision: v3.4.3 in the page history.
    Difference
    0.0%
    Check dated 2026-03-21T20:21:37.000Z thumbnail image
  5. Check
    70 days ago
    Change Detected
    Summary
    The 2026-03-04 revision (v3.4.3) adds Contacts/Locations and Study Status entries to the record history.
    Difference
    0.1%
    Check dated 2026-03-07T05:57:41.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:49:26.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the page footer and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-06T11:36:35.000Z thumbnail image

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.